Abstract:within 1 day after spinal cord injury (SCI) or ischemic stroke in mice 8,11 . Additionally, ATF3 protein levels in mouse blood significantly increased 1 day after SCI as well as after ischemic stroke 11 . Most importantly, ATF3 protein levels in human serum were elevated in patients within 24 hours after SCI or ischemic stroke 11 . These results demonstrate the feasibility of using ATF3 level in patients' serum as a potential biomarker for CNS trauma 11 .One of the primary contexts in which ATF3 has been studied is neuronal injury 12 . Following axonal damage, ATF3 expression is markedly increased in affected neurons, which is believed to contribute to the cellular response aimed at repair and regeneration 13 . For instance, in models of peripheral nerve injury, ATF3 has been shown to promote neurite outgrowth and to enhance the intrinsic growth capacity of neurons (reviewed in 14 ).Comparing RNA expression data across species that exhibit different abilities to regenerate their nervous system following traumatic nerve injury reveals that ATF3 is consistently induced in neurons within the first few days after injury. Thus, ATF3 can definitely be considered as an evolutionary conserved regulator of neuronal regeneration 14 .ATF3 also modulates the response of the CNS to inflammation and psychological stress. In conditions of neuroinflammation, such as those observed in multiple sclerosis and other neurodegenerative diseases, ATF3 expression is upregulated in glial cells (reviewed in 4 ), including astrocytes and microglia. This upregulation is associated with the modulation of inflammatory responses 15 , which can be either protective or detrimental depending upon the context and duration of the stressor. It has been mentioned that targeting microglial ATF3 upregulation to mitigate inflammation would be an interesting and necessary therapeutic avenue across a range of CNS disease 16 . Regarding cell death, ATF3 has been reported to be either pro-apoptotic or anti-apoptotic. For instance, the neuroinflammatory response during Alzheimer disease (AD) is triggered by microglia secreting pro-inflammatory cytokines, including CCL4, which attracts astrocytes to encapsulate plaques. Noteworthy, CCL4 is undetectable in normal brain, however, it is significantly present in AD brain at increased concentrations and is positively correlated with amyloid deposition. As ATF3 was found to bind to the promoter region of the CCL4 gene and to positively regulate its transcription, it was concluded that AD progression is controlled also by ATF3 which regulates the associated neuroinflammation pathways (reviewed in 17 ). In another study of a mouse model of Parkinson's diseases, ATF3-knockdown decreased CHOP (C/EBP-homologous protein) and cleaved caspase-3 levels (apoptotic markers), suggesting that ATF3 plays a role in apoptosis induction 18 . Additionally, in response to lipotoxic brain microvascular damage, ATF3 was found to mainly govern triglyceride-rich lipoprotein-induced inflammation and TNF signaling in the cerebrovascular system and increase endothelial cell apoptosis 19 .However, in ischemic stroke, ATF3 overexpression attenuated neuronal caspase-dependent apoptosis, microglial activation, and pro-inflammatory cytokine production to alleviate brain injury. ATF3 was also shown to reduce microglia activation and, by doing so, to prevent apoptosis. In addition, ATF3 was shown to prevent neuronal apoptosis by promoting the expression of the anti-apoptotic neuronal survival factor HSP27 and activation of Akt (reviewed in 20 ).Recent studies have explored the role of ATF3 in psychological stress response of the CNS. Chronic stress is known to induce changes in brain function and structure, contributing to mental health disorders like depression and anxiety 21,22 . ATF3 appears to be involved in the cellular mechanisms underlying these changes, influencing neuroplasticity and stress resilience.The multifaceted roles of ATF3 in the CNS suggest that it could become a valuable target for therapeutic interventions aimed at mitigating the effects of CNS stress. For example, enhancing ATF3 expression in neurons might promote recovery after traumatic brain injury or stroke (reviewed in 20 ). Additionally, modulating ATF3 activity in glial cells could help manage chronic neuroinflammation seen in diseases like Alzheimer's 17 and Parkinson's 23 .However, the dual nature of ATF3's actions-promoting repair in some contexts 24 while potentially exacerbating damage in others 17 -necessitates a nuanced approach to therapeutic development. Understanding the precise conditions under which ATF3 exerts its beneficial versus detrimental effects will be crucial for harnessing its potential in clinical settings.ATF3 is a pivotal transcription factor in the CNS response to all forms of stress, playing significant roles in neuronal injury repair, neuroinflammation, recovery from metabolic stress, a -Abstract Truncated-

Editorial: ATF3: a crucial stress-responsive gene of glia and neurons in CNS

ATF3 Prevents Stress-Induced Hematopoietic Stem Cell Exhaustion

IκBα Deficiency in Brain Leads to Elevated Basal Neuroinflammation and Attenuated Response Following Traumatic Brain Injury: Implications for Functional Recovery

Increased inflammation and brain injury after transient focal cerebral ischemia in activating transcription factor 3 knockout mice.

The multifaceted roles of activating transcription factor 3 (ATF3) in inflammatory responses - Potential target to regulate neuroinflammation in acute brain injury

ATF3 is a neuron‐specific biomarker for spinal cord injury and ischaemic stroke

The potential roles of ATF family in the treatment of Alzheimer's disease.

Activating Transcription Factor 3: A Potential Therapeutic Target for Inflammatory Pulmonary Diseases.

The Dual Roles of Activating Transcription Factor 3 (ATF3) in Inflammation, Apoptosis, Ferroptosis, and Pathogen Infection Responses

ATF4 orchestrates IL-1α-induced senescence in adult neural stem cells

TRAF6-p38/JNK-ATF2 Axis Promotes Microglial Inflammatory Activation

TRAF6-p38/JNK-ATF2 axis promotes microglial inflammatory activation.

Overexpression of Activating Transcription Factor 3 Alleviates Cardiac Microvascular Ischemia/Reperfusion Injury in Rats

Activating Transcription Factor 3 Protects against Restraint Stress-Induced Gastrointestinal Injury in Mice

ER stress mediated‑autophagy contributes to neurological dysfunction in traumatic brain injury via the ATF6 UPR signaling pathway

Atf3 mutant mice show reduced axon regeneration and impaired regeneration-associated gene induction after peripheral nerve injury

TFE3, a potential therapeutic target for Spinal Cord Injury via augmenting autophagy flux and alleviating ER stress

ATF3 expression in cardiomyocytes preserves homeostasis in the heart and controls peripheral glucose tolerance

Neuron-Specific Tumor Necrosis Factor Receptor–Associated Factor 3 is a Central Regulator of Neuronal Death in Acute Ischemic Stroke

A lifetime of stress: ATF6 in development and homeostasis

ATF4 Protects the Heart From Failure by Antagonizing Oxidative Stress